Home / Ophthalmology
Ophthalmology
| 9 min read
Cell therapies derived from stem cells could one day prevent vision loss or even restore sight in retinal degenerative disease.
| 9 min read
Injecting healthy, exogenous mitochondria into the eye could combat mitochondrial dysfunction and cell death in Fuchs endothelial corneal dystrophy.
| 10 min read
To dismantle healthcare barriers in low-resource areas, researchers measure the color signatures of jaundice and anemia using a device that’s in everyone’s pocket.
| 10+ min read
Eye injections are the only way to treat diabetic retinopathy, but many refuse to get them. Now, eye drops and pills are on their way.
| 7 min read
Researchers correcting the genetic causes of disease at the DNA or RNA level make their cases.
| 4 min read
Neuroscientists safely delivered a critical gene that improved vision for two patients with Leber congenital amaurosis.
| 5 min read
A new analysis shows huge variation in mutations for induced pluripotent stem cells, including some changes that can severely limit their ability to transform into other kinds of cells.
| 3 min read
Wolfram Syndrome is a rare disease that causes a myriad of challenges, including deafness, diabetes, and depression. New research suggests that an agonist used to treat neurodegenerative disorders may help alleviate some of the symptoms.
| 4 min read
Silicon nanoneedles loaded with ocular drugs hold potential to replace invasive injections to the eye.
| 4 min read
Age-related macular degeneration is the most common cause of vision loss in adults over age 50, but there are few treatments available. Researchers are now developing promising stem cell therapies to treat the disease.
| 10+ min read
Researchers are developing gene and cell therapies and prosthetics to help patients with blindness regain some vision. The first major prosthetic, the Argus II, was just discontinued. Where will the field go from here?
| 10+ min read
Between invasive surgery or risky laser therapy, people suffering from severe eye floaters have no great treatment options. Now, with the development of a safer and less invasive nanoparticle-based therapy, people with floaters may finally get their vision and quality of life back.
